Killer to cure: Expression and production costs calculation of tobacco plant-made cancer-immune checkpoint inhibitors.

Ridgley, Laura A; Falci Finardi, Nicole; Gengenbach, Benjamin B; Opdensteinen, Patrick; Croxford, Zack; Ma, Julian K-C; Bodman-Smith, Mark; Buyel, Johannes F; Teh, Audrey Y-H

Ridgley, Laura A; Falci Finardi, Nicole; Gengenbach, Benjamin B; Opdensteinen, Patrick; Croxford, Zack; Ma, Julian K-C; Bodman-Smith, Mark; Buyel, Johannes F; Teh, Audrey Y-H.

Afiliação

Ridgley LA; Institute for Infection and Immunity, St. George's, University of London, London, UK.
Falci Finardi N; Institute for Cancer Vaccines and Immunotherapy, London, UK.
Gengenbach BB; Institute for Infection and Immunity, St. George's, University of London, London, UK.
Opdensteinen P; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Aachen, Germany.
Croxford Z; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Aachen, Germany.
Ma JK; Institute for Infection and Immunity, St. George's, University of London, London, UK.
Bodman-Smith M; Institute for Infection and Immunity, St. George's, University of London, London, UK.
Buyel JF; Institute for Infection and Immunity, St. George's, University of London, London, UK.
Teh AY; Institute for Cancer Vaccines and Immunotherapy, London, UK.

Plant Biotechnol J ; 21(6): 1254-1269, 2023 06.

Article em En | MEDLINE | ID: mdl-36811226

Assuntos

Neoplasias; Nicotiana; Animais; Humanos; Nicotiana/genética; Inibidores de Checkpoint Imunológico; Receptores de IgG; Mamíferos

Palavras-chave

Cancer; Immune checkpoint inhibitors; NK cell; Plant expression vector; T-cell; production cost model

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nicotiana / Neoplasias Tipo de estudo: Health_economic_evaluation Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google